A short clip aimed at new mothers thinking about restarting GLP-1s like Ozempic or Wegovy while nursing, with a caution to hear first.
Recap by typeshit. Video by Doc Tok Podcast on TikTok.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
People on GLP-1 medicines reported nail issues, including nails separating from the skin, more often than non-users in a new survey.
NexLife put out a monthly index tracking what online sellers charge for compounded GLP-1 drugs. Only the announcement title is available so far.
Loading…